Chunhung Wu1, Xin-Qi Cai1, Yu Chang2, Chueh-Hsuan Chen1, Tsung-Jung Ho3,4, Shang-Chih Lai5,6, Hao-Ping Chen2,4. 1. Department of Chemistry, Tamkang University, New Taipei City, Taiwan. 2. Department of Biochemistry, Tzu Chi University, Hualien, Taiwan. 3. Department of Chinese Medicine, Tzu Chi General Hospital, Hualien, Taiwan. 4. Integration Centre of Traditional Chinese and Modern Medicine, Tzu Chi General Hospital, Hualien, Taiwan. 5. School of Post-Baccalaureate Chinese Medicine, Tzu Chi University, Hualien, Taiwan. 6. Department of Pharmacy, Tzu Chi General Hospital, Hualien, Taiwan.
Abstract
INTRODUCTION: Dragon blood is a deep-red plant resin which has been used as folk medicine for more than a thousand years. It can be produced from at least four entirely different plant families: Asparagaceae, Arecaceae, Chamaesyce, and Fabaceae. Current pharmacopeia states that the only "authentic" source of dragon blood is the palm tree, Daemonorops draco. OBJECTIVE: The present study aims to find a high-throughput method to screen and identify the plant sources of commercial dragon blood products. METHODOLOGY: A matrix-assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) based method for rapid screening of dracorhodin in commercial dragon blood samples was established in this study. RESULTS: Well-resolved peaks of dracorhodin in spectra were observed in the crude extracts of samples. Dragon blood samples from two other plant species, Dracaena cinnabari and Dracaena cochinchinensis, were also examined. Their indicator compounds, loureirin A and B, were detected in these plants. CONCLUSION: A MALDI-TOF based method for preliminarily examination of commercial dragon blood samples is reported here. In contrast to MALDI-TOF, liquid chromatography mass spectrometry (LC-MS) is a time-consuming and costly method, not ideal for routine and large-scale screening of commercial samples.
INTRODUCTION: Dragon blood is a deep-red plant resin which has been used as folk medicine for more than a thousand years. It can be produced from at least four entirely different plant families: Asparagaceae, Arecaceae, Chamaesyce, and Fabaceae. Current pharmacopeia states that the only "authentic" source of dragon blood is the palm tree, Daemonorops draco. OBJECTIVE: The present study aims to find a high-throughput method to screen and identify the plant sources of commercial dragon blood products. METHODOLOGY: A matrix-assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) based method for rapid screening of dracorhodin in commercial dragon blood samples was established in this study. RESULTS: Well-resolved peaks of dracorhodin in spectra were observed in the crude extracts of samples. Dragon blood samples from two other plant species, Dracaena cinnabari and Dracaena cochinchinensis, were also examined. Their indicator compounds, loureirin A and B, were detected in these plants. CONCLUSION: A MALDI-TOF based method for preliminarily examination of commercial dragon blood samples is reported here. In contrast to MALDI-TOF, liquid chromatography mass spectrometry (LC-MS) is a time-consuming and costly method, not ideal for routine and large-scale screening of commercial samples.